Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bettina Wedi

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Expert Opinion on Investigational Drugs|February 15, 2022
Emerging treatments for chronic urticariaBettina Wedi
Current Opinion in Allergy and Clinical Immunology|August 1, 2025
Biologic and small molecule therapies in chronic spontaneous urticaria: an updateBettina Wedi
Expert Review of Clinical Pharmacology|November 25, 2011
Definitions and mechanisms of drug hypersensitivityBettina Wedi
Expert Opinion on Biological Therapy|May 9, 2020
Ligelizumab for the treatment of chronic spontaneous urticariaBettina Wedi
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|July 17, 2020
[Are cationic amphiphilic H1 antihistamines useful as adjuvant treatment of malignant melanoma?]Bettina Wedi
Frontiers in Allergy|April 7, 2022
Contemporary Grand Challenges and Opportunities in Skin AllergiesBettina Wedi
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 2, 2008
UrticariaBettina Wedi
Deutsche Medizinische Wochenschrift (1946)|December 16, 2016
[Christmas from an allergist's perspective]Bettina Wedi
Expert Opinion on Investigational Drugs|October 28, 2023
Inhibition of KIT for chronic urticaria: a status update on drugs in early clinical developmentBettina Wedi
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|May 2, 2019
[Coming into focus: dipeptidyl peptidase 4 inhibitors (gliptins)]Bettina Wedi
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Expert Opinion on Investigational Drugs|February 15, 2022
Emerging treatments for chronic urticariaBettina Wedi
Current Opinion in Allergy and Clinical Immunology|August 1, 2025
Biologic and small molecule therapies in chronic spontaneous urticaria: an updateBettina Wedi
Expert Review of Clinical Pharmacology|November 25, 2011
Definitions and mechanisms of drug hypersensitivityBettina Wedi
Expert Opinion on Biological Therapy|May 9, 2020
Ligelizumab for the treatment of chronic spontaneous urticariaBettina Wedi
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|July 17, 2020
[Are cationic amphiphilic H1 antihistamines useful as adjuvant treatment of malignant melanoma?]Bettina Wedi
Frontiers in Allergy|April 7, 2022
Contemporary Grand Challenges and Opportunities in Skin AllergiesBettina Wedi
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 2, 2008
UrticariaBettina Wedi
Deutsche Medizinische Wochenschrift (1946)|December 16, 2016
[Christmas from an allergist's perspective]Bettina Wedi
Expert Opinion on Investigational Drugs|October 28, 2023
Inhibition of KIT for chronic urticaria: a status update on drugs in early clinical developmentBettina Wedi
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|May 2, 2019
[Coming into focus: dipeptidyl peptidase 4 inhibitors (gliptins)]Bettina Wedi
Pageof 10